-
COVID Cases Rise Again – but Don’t Overreact
Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains more ground. On July 19, CDC vaccine advisers unanimously approved recommended the use of the Novavax COVID-19 vaccine for the primary series for people 18 years and older. The CDC…
-
BA.5 Continues Transmission, but Severity is Low
Key Points: In today’s Recommendation for Industry, we discuss BA.5’s continued transmission and low severity. Read more below. FDA green-lights Novavax vaccine as COVID-19 levels rise: While the FDA has approved emergency use authorization for Novavax vaccine, the CDC must recommend it before it can be administered. The CDC Advisory Committee on Immunization Practices (ACIP)…
-
Westward Wave of COVID Continues – as Projected
Key Points: In today’s Recommendation for Industry, we discuss the continued westward wave of COVID. Read more below. Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvante. On July 13, the USDA issued an emergency use authorization for Novavax COVID-19, Adjuvante vaccine for individuals 18 years of age and older. The FDA…
-
Question on COVID Transmission from Packaging Resurfaces
Key Points: In today’s Recommendation for Industry, we discuss the possibility of COVID transmission from packaging. Read more below. Nitric oxide boosts oxygen in pregnant women with COVID-19 pneumonia. Inhaled high-dose nitric oxide (INO200) safely shortened time on supplemental oxygen and hospital stays among pregnant women diagnosed as having severe bilateral COVID-19 pneumonia, suggests a…
-
Current Status & Trajectory of COVID
Key Points: In today’s Recommendation for Industry, we discuss the continued westward movement of COVID in the U.S. Read more below. BA.4/5 COVID-19 variants now dominant in all US regions. Combined, the two subvariants make up more than 70% of recently sequenced samples, up sharply from 52.3% the previous week. Of the variants CDC is…
-
TAG Recommendations for COVID and Monkeypox
Key Points: In today’s Recommendation for Industry, we provide current updates and recommendations on COVID and Monkeypox transmission. Read more below. COVID vaccines prevented poor outcomes in people of all sizes. COVID-19 vaccination protected people of all body sizes from hospitalization and death—although vaccinated people with a low or high body mass index (BMI) were…
-
COVID Westward Migration Continues
Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read more below. FDA advisory committee is recommending Omicron variant to be within COVID boosters. The proportion of BA.4 and BA.5 increased in the week ending June 25th, mainly due to…
-
COVID-19 & Monkeypox Updates
Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response. A modified booster shot targeting Omicron specifically increased neutralizing antibody levels 13.5 to 19.6 times higher than the current shot. A booster targeting both Omicron and the original virus increased…
-
COVID: Progressive Trajectories Very Encouraging
Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women more likely to have long COVID, different symptom profile. For the shorter-term COVID, females were more likely than males to experience issues related to mood; ear, nose, and throat; musculoskeletal;…
-
Monkeypox: Steps Businesses Can Take to Keep Risk Low
Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it low. Read more below. Omicron is as much as 50% less likely to lead to long COVID, study finds. The numbers of individuals that were infected with Omicron were more…